BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 34602314)

  • 1. Undifferentiated and dedifferentiated soft tissue neoplasms: Immunohistochemical surrogates for differential diagnosis.
    Thway K; Fisher C
    Semin Diagn Pathol; 2021 Nov; 38(6):170-186. PubMed ID: 34602314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclassification of pleomorphic sarcomas: How and why should we care?
    Hornick JL
    Ann Diagn Pathol; 2018 Dec; 37():118-124. PubMed ID: 30340082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
    Keung EZ; Lazar AJ; Torres KE; Wang WL; Cormier JN; Ashleigh Guadagnolo B; Bishop AJ; Lin H; Hunt KK; Bird J; Lewis VO; Patel SR; Wargo JA; Somaiah N; Roland CL
    BMC Cancer; 2018 Sep; 18(1):913. PubMed ID: 30249211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
    Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
    Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2020 WHO Classification: What's New in Soft Tissue Tumor Pathology?
    Kallen ME; Hornick JL
    Am J Surg Pathol; 2021 Jan; 45(1):e1-e23. PubMed ID: 32796172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling undifferentiated soft tissue sarcomas: insights from genomics.
    Hames-Fathi S; Nottley SWG; Pillay N
    Histopathology; 2022 Jan; 80(1):109-121. PubMed ID: 34958500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pathologic diagnosis of bone and soft tissue tumors: update].
    Nojima T
    Rinsho Byori; 2014 Jun; 62(6):578-85. PubMed ID: 25151777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleomorphic liposarcoma: Updates and current differential diagnosis.
    Anderson WJ; Jo VY
    Semin Diagn Pathol; 2019 Mar; 36(2):122-128. PubMed ID: 30852046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleomorphic Sarcomas: The State of the Art.
    Carvalho SD; Pissaloux D; Crombé A; Coindre JM; Le Loarer F
    Surg Pathol Clin; 2019 Mar; 12(1):63-105. PubMed ID: 30709449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
    Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
    J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
    Chung L; Lau SK; Jiang Z; Loera S; Bedel V; Ji J; Weiss LM; Chu PG
    Am J Surg Pathol; 2009 Nov; 33(11):1594-600. PubMed ID: 19574885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Round Cell Sarcomas: Newcomers and Diagnostic Approaches.
    Nagy A; Somers GR
    Surg Pathol Clin; 2020 Dec; 13(4):763-782. PubMed ID: 33183732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcomas of the mediastinum with epithelioid morphology.
    Perry KD; Montecalvo J; Perry AM
    Mediastinum; 2021; 5():4. PubMed ID: 35118310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of pleomorphic/undifferentiated and dedifferentiated bone neoplasms.
    Brčić I; Rosenberg AE
    Semin Diagn Pathol; 2021 Nov; 38(6):163-169. PubMed ID: 34049746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High IGF2 and FGFR3 are associated with tumour progression in undifferentiated pleomorphic sarcomas, but EGFR and FGFR3 mutations are a rare event.
    Rüping K; Altendorf-Hofmann A; Chen Y; Kampmann E; Gibis S; Lindner L; Katenkamp D; Petersen I; Knösel T
    J Cancer Res Clin Oncol; 2014 Aug; 140(8):1315-22. PubMed ID: 24804818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rare primary bone sarcomas: imaging-pathological correlation.
    Berkeley R; Andrei V; Saifuddin A
    Skeletal Radiol; 2021 Aug; 50(8):1491-1511. PubMed ID: 33410967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.